Saudi Arabia IVF (in-vitro fertilization) Market Overview, 2029

Saudi Arabia's rise to prominence in the In Vitro Fertilisation (IVF) industry is a testament to its dedication to improving healthcare and tackling reproductive concerns. Propelled by a number of factors such as rising awareness, government actions that are supportive, and technical breakthroughs, the IVF sector in Saudi Arabia has experienced substantial growth and development. When the first IVF clinics opened in the late 1970s and early 1980s, the Kingdom's adventure in the field of in vitro fertilisation started. Since then, the industry has grown quickly, and there are now a large number of specialised reproductive centres in operation all throughout the nation.

Preimplantation genetic testing (PGT), IVF, intracytoplasmic sperm injection (ICSI), and egg freezing are just a few of the many procedures provided by these centres. The high rate of infertility in the country is one of the factors propelling the IVF industry's expansion in Saudi Arabia. According to studies, a sizable portion of couples in the nation struggle with infertility, which has raised demand for assisted reproductive technologies (ART) like IVF. The need for IVF treatments has also increased due to social reasons that have led to the growth in infertility rates, such as postponing marriage and having children as well as changes in lifestyle.

The IVF industry in Saudi Arabia is vital to the assistance of couples with genetic abnormalities or other inherited illnesses, in addition to treating infertility. Couples hoping to stop genetic illnesses from passing on to their children are increasingly turning to PGT, which enables embryos to be screened for genetic abnormalities prior to implantation. This technique has given hope to couples suffering genetic problems and has greatly increased the success rates of IVF treatments. The Saudi government has acknowledged the significance of the IVF industry in addressing reproductive health concerns and has acted pro-actively to encourage and regulate it.

Fertility centre licencing and certification are supervised by the Ministry of Health, which also makes sure that the rules and regulations are followed. Furthermore, through a number of healthcare initiatives, the government offers financial support to qualified couples receiving IVF treatment, expanding the accessibility of these treatments to a larger demographic.

With continuous technological and scientific developments promising additional increases in success rates and treatment outcomes, the future of the IVF industry in Saudi Arabia is bright. Sustaining the development and quality of the IVF industry will need ongoing investments in training, research, and infrastructure. This will eventually enable the Kingdom's infertile couples to realise their dream of starting a family.

According to the research report, the Saudi Arabia Infertility Treatment market is anticipated to grow at more than 8.5% CAGR from 2024 to 2029. Saudi Arabia encounters several obstacles in the in vitro fertilisation (IVF) industry, such as hurdles based on culture and religion, restricted availability of specialised healthcare services in isolated regions, and exorbitant treatment costs. IVF treatments may not be widely accepted or used due to cultural and religious conventions around reproductive health, such as modesty concerns and prohibitions on gender mixing.

Furthermore, unequal access to reproductive clinics and experts is a common consequence of the population's geographic dispersion, especially in rural regions with inadequate healthcare infrastructure. Many Saudi families find it difficult to afford the high costs of IVF operations, which include consultation fees, drug costs, and the actual process, which restricts their capacity to pursue fertility treatments.

The assisted reproductive technology (ART) market in Saudi Arabia is changing, with different cycle types meeting different demands. Of these, the Fresh Non-donor IVF Cycle is one of the most popular options for a lot of couples. In this cycle, eggs are taken from the intended mother, sperm fertilisation occurs in a lab, and the resultant embryos are placed in the uterus. This cycle is appealing since it is quick and allows couples to receive therapy without having to freeze their embryos beforehand. The Fresh Non-donor IVF Cycle's appeal is mostly driven by its possibility for success and its immediacy in a culture that places a high importance on family relationships.

The use of the Frozen Non-donor IVF Cycle is becoming more widespread in Saudi Arabia's reproductive healthcare system. Using this technique, embryos from a prior Fresh Non-donor IVF Cycle are cryopreserved for future use. In Saudi Arabia, where cultural and religious factors may affect when to begin family planning, many couples find that the ease and flexibility this method offers suits their needs well. The rising popularity of the Frozen Non-donor IVF Cycle can be attributed to the increased control individuals have over their reproductive journey, which comes with the possibility to freeze embryos for future use.

The Frozen Donor IVF Cycle has been a popular option for Saudi Arabians dealing with certain infertility issues in recent years. Donated eggs or sperm are used in this cycle; they are fertilised and cryopreserved for use at a later time. In addition to providing a solution for infertile individuals, donor gametes' accessibility and anonymity help alleviate societal concerns about genetic parenthood. Expanding access to reproductive therapy throughout Saudi Arabia can be greatly aided by the Frozen Donor IVF Cycle, especially as knowledge and acceptance of third-party reproduction continue to rise. All cycle types have advantages, however in the Saudi Arabian context, there is a growing demand for the Fresh Donor IVF Cycle.

Compared to conventional IVF procedures, this technique gives patients a better chance of success since it uses fresh donor eggs or sperm. Reproductive technological improvements and the availability of new donor gametes have increased the success rate of fertility treatment results for couples. Consequently, the Fresh Donor IVF Cycle is starting to gain popularity among Saudi Arabians seeking assisted reproduction, signalling the beginning of a new chapter full of opportunity and optimism for both individuals and families.

Couples with infertility have hope thanks to major developments in assisted reproductive technology (ART), which has been implemented in Saudi Arabia and many other nations. Conventional IVF (In Vitro Fertilisation) is still a commonly used procedure in the country. In a typical IVF procedure, an egg is fertilised with sperm outside of the body in a lab dish, and the resultant embryo or embryos are then placed into the uterus. Many couples seeking fertility therapy in Saudi Arabia continue to choose this approach, which has been in use for decades. Another method known as IVF with ICSI (Intracytoplasmic Sperm Injection) has become more popular in the nation in recent years.

ICSI is the process of directly injecting one sperm into an egg to help in fertilisation. Couples dealing with male infertility concerns - such as poor sperm count or challenges with sperm motility - will find this treatment very helpful. IVF with ICSI has grown more successful and accessible in Saudi Arabia thanks to technological and professional developments, making it a top option for many couples seeking reproductive therapy. The use of donor eggs in IVF has grown in popularity in Saudi Arabia. Using the intended father's sperm, the eggs from a different woman - usually a younger, fertile one - are fertilised in this way.

For couples in which one of the female partners may have decreased ovarian reserve or other issues affecting egg quality, in vitro fertilisation (IVF) using donor eggs presents a feasible option. The use of donor eggs may be subject to cultural and religious restrictions in Saudi Arabia, however needy couples now have easier access to this alternative because to rising public knowledge of and acceptance of ART techniques. In addition to these traditional techniques, new and inventive methods and technology are always being developed in the area of ART.

The Kingdom of Saudi Arabia is experiencing a surge in the use of alternative reproductive therapies and procedures due to its expanding healthcare infrastructure and emphasis on technical breakthroughs. Preimplantation genetic testing (PGT), embryo freezing (cryopreservation), and cutting-edge methods to improve embryo selection and implantation success rates are a few examples of these.

Every end user has a unique role in the ever-changing healthcare environment of Saudi Arabia, which is shaped by cultural, economic, and regulatory variables. Fertility clinics are one of them that stands out as a rapidly expanding and in-demand industry. The importance of family and genealogy in Saudi Arabian culture greatly adds to the popularity of reproductive clinics. These clinics are seeing an increase in individuals seeking help in beginning or growing their families due to breakthroughs in reproductive technology and growing knowledge about infertility treatments.

The expansion of fertility clinics in the Kingdom is also aided by government funding in the form of programmes and policies designed to improve access to reproductive healthcare. Hospitals and Surgical Centres are essential to Saudi Arabia's healthcare system, even as Fertility Clinics prosper. The need for hospital and surgical services is always high due to the expanding population, rising rates of chronic illnesses, and problems connected to lifestyle choices. Furthermore, all residents are guaranteed access to high-quality treatment through government expenditures in healthcare infrastructure and the adoption of universal health coverage.

Because of this ongoing need as well as improvements in medical processes and technology, hospitals and surgical centres are now essential components of the Saudi healthcare system. Even though they are still a relatively new idea in Saudi Arabia, cryobanks are gaining popularity and speed quickly. Cryobanks are becoming indispensable institutions as the need for preserving reproductive cells and tissues becomes more widely recognised. In addition to providing hope to individuals and couples struggling with infertility, the preservation of gametes and embryos aids in medical research and advances in regenerative medicine.

These facilities have a great deal of room to grow and flourish in the Kingdom due to the growing acceptability and demand for cryopreservation services. Saudi Arabia's aim to invest in knowledge-based sectors and diversify its economy is driving a transformative era for the country's research institutes. These institutes, which get large money for research and development projects, are encouraging creativity and cooperation among scientists from different fields.

Years considered in this report:

• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029

Aspects covered in the report:

• IVF market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendations

By cycle:

• Fresh Non-donor IVF Cycle
• Frozen Non-donor IVF Cycle
• Frozen donor IVF Cycle
• Fresh donor IVF Cycle

By Conventional IVF:

• Conventional IVF
• IVF with ICSI (Instracytoplasmic Sperm Injection)
• IVF With Donor Eggs
• other

By End user:

• Fertility Clinics
• Hospital & Surgical Centers
• Cryobanks
• Research institute

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases.

After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. After this, the analysts made primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once they acquired the primary data, they started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the IVF industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.